Showing results (571-580 of 2,448) with videos related to
Sort By:
Pageof 245
Journal of Bacteriology|September 1, 1981
High-affinity arabinose transport mutants of Escherichia coli: isolation and gene locationA F Clark, R W HoggIn Vitro|July 1, 1975
Host effect on vesicular stomatitis virus morphogenesis and "T" particle formation in reptilian, avian, and mammalian cell linesP D Lunger, H F ClarkPediatric Dentistry|May 7, 2002
Outcomes for root-fractured permanent incisors: a retrospective studyR Welbury, M J Kinirons, P Day, et al.Harm Reduction Journal|December 5, 2024
Exploring drug consumption rooms as 'inclusion health interventions': policy implications for EuropeBenjamin D Scher, Benjamin W Chrisinger, David K Humphreys, et al.Health & Place|February 16, 2018
OpenStreetMap data for alcohol research: Reliability assessment and quality indicatorsJonathan Bright, Stefano De Sabbata, Sumin Lee, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1979
Treatment of Parkinson's disease with sodium valproate: clinical, pharmacological, and biochemical observationsJ Nutt, A Williams, C Plotkin, et al.Neuropharmacology|April 1, 1988
Chronic benzodiazepine treatment increases the effects of the inverse agonist FG7142H J Little, R Gale, N Sellars, et al.Annals of the New York Academy of Sciences|March 19, 2004
In vivo estimation of imidazoline(2) binding site turnoverL M Paterson, E S J Robinson, D J Nutt, et al.Acta Poloniae Pharmaceutica|April 6, 2006
Preparation, structure and affinity for imidazoline I2 receptors and alpha2-adrenoceptors of 1-[(4,5-dihydroimidazolidin-2-yl)imino]indan-2-olsAnita Kornicka, Franciszek Saczewski, Robin J Tyacke, et al.Journal of Psychopharmacology (Oxford, England)|March 15, 2006
A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteersJayne E Bailey, Adrian Kendrick, Alison Diaper, et al.Pageof 245